Trovagene said this week that Carlo Croce has joined its scientific advisory board.
Croce is chair of human genetics and chairman of molecular virology, immunology, and medical genetics at the Genetics Institute at Ohio State University. He also serves as director of the human cancer genetics program at the institute.
Croce also co-founded Centocor, which was acquired by Johnson & Johnson in 1999.